INVESTIGATIONAL — IN CLINICAL TRIALS
What is Cagrilintide?
Cagrilintide is a long-acting amylin analog. Amylin is a hormone co-secreted with insulin that plays a role in appetite regulation and glucose control. Cagrilintide is being studied particularly in combination with GLP-1 receptor agonists for potentially additive effects.
Areas of Research Interest
- Amylin receptor pathway studies
- Combination therapy research with GLP-1 agonists
- Appetite regulation and satiety research
- Body weight management clinical trials
Regulatory Status
Cagrilintide is investigational and currently undergoing clinical trials, often studied in combination with other compounds. It has not received FDA approval for any use as a standalone or combination therapy.
Educational information only. This content is not intended to diagnose, treat, cure, or prevent any disease, and does not provide guidance on personal use, dosing, or administration. Consult qualified professionals and current regulatory sources for guidance specific to your situation.